Is creatine kinase a valid aid in early cardiac muscle damage detection during treatment for childhood acute lymphoblastic leukemia? A case report - Scorecard - MDSpire

Is creatine kinase a valid aid in early cardiac muscle damage detection during treatment for childhood acute lymphoblastic leukemia? A case report

  • By

  • Grazia Fazio

  • Jari Intra

  • Orsola Montini

  • Laura Rachele Bettini

  • Giacomo Gotti

  • Alessandra Sala

  • Silvia Bungaro

  • Giovanni Cazzaniga

  • Carmelo Rizzari

  • Adriana Balduzzi

  • Marco Casati

  • May 1, 2026

  • 0 min

Share

Clinical Scorecard: Evaluating the Role of Creatine Kinase in Early Detection of Cardiac Muscle Injury During Treatment for Pediatric Acute Lymphoblastic Leukemia: A Case Study

At a Glance

CategoryDetail
Condition
Key MechanismsElevated creatine kinase (CK) levels may indicate cardiac muscle injury during chemotherapy, as evidenced by case findings.
Target Population
Care Setting

Key Highlights

  • additional_data

Guideline-Based Recommendations

Diagnosis

    Management

    • Utilize risk stratification and intensified chemotherapy protocols based on CK monitoring results.

    Monitoring & Follow-up

      Risks

        Patient & Prescribing Data

        Asymptomatic elevations in CK levels may necessitate adjustments in chemotherapy regimens.

        Clinical Best Practices

        • rationale

        References

        Original Source(s)

        Is creatine kinase a valid aid in early cardiac muscle damage detection during treatment for childhood acute lymphoblastic leukemia? A case report

        • by Grazia Fazio, Jari Intra, Orsola Montini, Laura Rachele Bettini, Giacomo Gotti, Alessandra Sala, Silvia Bungaro, Giovanni Cazzaniga, Carmelo Rizzari, Adriana Balduzzi, Marco Casati

        • May 1, 2026

        Related Content

        Trametinib as second-line therapy for advanced KRAS G12C-mutant non-small cell lung cancer: a single-center clinical analysis of 20 cases

        Use of PCSK9 Inhibitors Among Patients Receiving Immune Checkpoint Inhibitors for Cancer

        Bilateral renal metastasis following radical prostatectomy for prostate cancer: a case report